Osiris Therapeutics gets last Osteocel payment after NuVasive reports $35M in Osteocel revenue
Minnesota business by the numbers See Minnesota's top earning companies, CEOs and non-profits NEW YORK - Osiris Therapeutics Inc. said Tuesday it received a $15 million payment from NuVasive Inc., the final milestone fee linked... [read full story]
|
RELATED
|
|
Osiris Therapeutics reports financial results for the third quarter of 2009
Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its...
Osiris Therapeutics Reports Third Quarter 2009 Financial Results
Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced...
Osiris Therapeutics gets last Osteocel payment after NuVasive reports $35M in Osteocel revenue
NEW YORK (AP) — Osiris Therapeutics Inc. said Tuesday it received a $15 million payment from NuVasive Inc., the final milestone fee linked to the sale of Osiris' bone graft stem cell business. San Diego-based NuVasive agreed to...
Osiris gets $15M milestone payment from NuVasive
Osiris Therapeutics Inc. said Tuesday it received a $15 million payment from NuVasive Inc., the final milestone fee linked to the sale of Osiris' bone graft stem cell business. The Associated Press NEW YORK — Osiris...
Osiris gets $15M milestone payment from NuVasive (AP)
Osiris Therapeutics gets last Osteocel payment after NuVasive reports $35M in Osteocel revenue NEW YORK (AP) -- Osiris Therapeutics Inc. said Tuesday it received a $15 million payment from NuVasive Inc., the final milestone fee...
Osiris gets $15M milestone payment from NuVasive
NEW YORK (AP) - Osiris Therapeutics Inc. said Tuesday it received a $15 million payment from NuVasive Inc., the final milestone fee linked to the sale of Osiris' bone graft stem cell business. San Diego-based NuVasive agreed to...
Osiris gets $15M milestone payment from NuVasive
— Osiris Therapeutics Inc. said Tuesday it received a $15 million payment from NuVasive Inc., the final milestone fee linked to the sale of Osiris' bone graft stem cell business. San Diego-based NuVasive agreed to buy the...
Osiris gets $15M milestone payment from NuVasive
NEW YORK — Osiris Therapeutics Inc. said Tuesday it received a $15 million payment from NuVasive Inc., the final milestone fee linked to the sale of Osiris' bone graft stem cell business. San Diego-based NuVasive agreed to buy...
Osiris gets $15M milestone payment from NuVasive
Osiris Therapeutics Inc. said Tuesday it received a $15 million payment from NuVasive Inc., the final milestone fee linked to the sale of Osiris' bone graft stem cell business. San Diego-based NuVasive agreed to buy the...
Osiris gets $15M milestone payment from NuVasive
Osiris Therapeutics Inc. said Tuesday it received a $15 million payment from NuVasive Inc., the final milestone fee linked to the sale of Osiris' bone graft stem cell business. San Diego-based NuVasive agreed to buy the...
Related categories
Nuvasive, North America, United States of America, Minnesota
International Editions
English - US | English - UK | Deutsch | Français | Español - España | Português - Portugal | Italiano | Čeština | Русский (Russian) | عربي (Arabic) | 中文（简）(Simplified Chinese) | Español - México | Português - Brasil | 한국어 (Korean) | English - India
